discovered that FcγR-dependent M1-type macrophage-mediated ADCP was essential for maintaining anti-lymphoma activity, suggesting that strategies promoting the recruitment of M1-type macrophages or repolarization of macrophages could enhance the response to immunotherapy in lymphoma (26). The gene discussed is FCGR2A; the disease is lymphoma.